Drug Clinical Trials List

Study Title	Study Sponsor	Status	Study Drug	Trial Phase	Study Protocol Number	Site
Daily practice treatment and Influence of Visanne on the patient Assessment of quality of life parameters	Bayer	Completed	Visanne	4	VS1101	King Khalid University Hospital (Riyadh), Soliman Fakeeh Hospital (Jeddah)
An Open-Label, Randomized Naturalistic Study to Evaluate the Incidence of Hypoglycemia Comparing Sitagliptin With Sulfonylurea Treatment in Patients With Type 2 Diabetes During Ramadan Fasting	MSD	Completed	Sitagliptin	4	MK0431-263	Al-Noor Specialist Hospital (Makkah), Armed Forces Hospital (Al-Hada), King Fahad University Hospital (Al-Khobar), Riyadh Care Hospital, Al Alam Medical Center (Riyadh)
A 20-week Study Comparing Patient-adjusted Versus Physician-adjusted Titration of BIAsp 30 Combined With Metformin in Type 2 Diabetes Patients Uncontrolled on NPH Insulin	Novonordisk	Completed	BIAsp 30 / Metformin	4	BIAsp 3968	King Abdulaziz Medical City NG (Riyadh), King Faisal Specialist Hospital and Research Center (Riyadh), King Abdulaziz University Hospital (Jeddah), Armed Forces Hospital (Al-Hada)
A multicentre, prospective observational cohort study to assess the effects of vildagliptin relative to sulphonylurea as dual therapy with metformin (or as monotherapy) in Muslim patients with type 2 diabetes fasting during Ramadan	Novartis	Completed	Vildagliptin / Sulphonylurea / Metformin	4	CLAF237A-MAX-AE-02	Soliman Fakeeh Hospital (Jeddah)
A Multicenter, Prospective, Observational, Non-Interventional Cohort Study Evaluating On-Treatment Predictors of Response in Subjects With HBeAg Positive and HBeAg Negative Chronic Hepatitis B Receiving Therapy With PEGASYS(R) (Peginterferon Alfa-2a 40KD)	Roche	Completed	Pegasys	4	MV22009	King Fahad University Hospital (Al-Khobar), Armed Forces Hospital (Kharj)
UNraveling nAMD real life Clinical management and Outcome with intraVitrEal Ranibizumab injection – A retrospective analysis (UNCOVER)	Novartis	Completed	Ranibizumab	4	CRFB0021	King Khaled Eye Specialist Hospital (Riyadh)
A double blind, Double Dummy, Randomized, Multi-Centre study to assess the tolerability and Efficacy Profile of Vildagliptin Compared to Gliclazide as Dual Therapy with Metformin in Muslim Patients with Type 2 Diabetes Fasting During Ramadan.	Novartis	Completed	Vildagliptin /Gliclazide / Metformin	4	CLAF237A2411	King Fahad University Hospital (Al-Khobar)_ King Abdulaziz Medical City NG (Riyadh)
A Phase III, Multicentre, International, Randomised, Parallel Group, Double Blind Cardiovascular Safety Study of BI 10773 (10 mg and 25 mg Administered Orally Once Daily) Compared to Usual Care in Type 2 Diabetes Mellitus Patients With Increased Cardiovascular Risk	Boehringer Ingelheim	Completed	BI 10773	3	1245.25	King Fahad Medical City (Riyadh)
Global Study to Assess the Addition of Bevacizumab to Carboplatin and Paclitaxel as Front-line Treatment of Epithelial Ovarian Cancer, Fallopian Tube Carcinoma or Primary Peritoneal Carcinoma	Roche	Completed	Bevacizumab	3	MO22923	King Fahad Medical City (Riyadh)_ King Fahad Specialist Hospital (Dammam)
An Open Label, Multicenter, Dose Escalation Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of SBC-102 (Sebelipase Alfa) in Children With Growth Failure Due to Lysosomal Acid Lipase Deficiency	Synageva	Completed	Sebelipase alfa (SBC-102)	2	LAL-CL03	King Faisal Specialist Hospital and Research Center (Riyadh)